$2.45
0.114.70%
At close: -
$2.38
-0.07-2.92%
After Hours: 5:08 PM EDT
Comments
Loading...
Medicus Pharma Analyst Ratings and Price Targets | NASDAQ:MDCX | Benzinga
Medicus Pharma Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Medicus Pharma Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
D. Boral Capital
Maxim Group
1calculated from analyst ratings
Analyst Ratings for Medicus Pharma
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/23/2025 | Buy Now | — | D. Boral Capital | Jason Kolbert52% | $27 → $27 | Maintains | Buy | Get Alert |
| 06/09/2025 | Buy Now | — | D. Boral Capital | Jason Kolbert52% | $27 → $27 | Maintains | Buy | Get Alert |
| 05/29/2025 | Buy Now | — | D. Boral Capital | Jason Kolbert52% | $27 → $27 | Maintains | Buy | Get Alert |
| 05/22/2025 | Buy Now | — | D. Boral Capital | Jason Kolbert52% | $27 → $27 | Maintains | Buy | Get Alert |
| 05/12/2025 | Buy Now | — | D. Boral Capital | Jason Kolbert52% | $14 → $27 | Maintains | Buy | Get Alert |
| 05/08/2025 | Buy Now | — | Maxim Group | Jason McCarthy42% | $10 → $20 | Maintains | Buy | Get Alert |
| 04/28/2025 | Buy Now | — | D. Boral Capital | Jason Kolbert52% | $14 → $14 | Maintains | Buy | Get Alert |
| 04/21/2025 | Buy Now | — | D. Boral Capital | Jason Kolbert52% | $14 → $14 | Maintains | Buy | Get Alert |
| 04/14/2025 | Buy Now | — | D. Boral Capital | Jason Kolbert52% | → $14 | Initiates | → Buy | Get Alert |
| 12/17/2024 | Buy Now | — | Maxim Group | Jason McCarthy42% | → $10 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Medicus Pharma (MDCX) stock?
The latest price target for Medicus Pharma (NASDAQ:MDCX) was reported by D. Boral Capital on June 23, 2025. The analyst firm set a price target for $27.00 expecting MDCX to rise to within 12 months (a possible 1035.17% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Medicus Pharma (MDCX)?
The latest analyst rating for Medicus Pharma (NASDAQ:MDCX) was provided by D. Boral Capital, and Medicus Pharma maintained their buy rating.
When was the last upgrade for Medicus Pharma (MDCX)?
There is no last upgrade for Medicus Pharma
When was the last downgrade for Medicus Pharma (MDCX)?
There is no last downgrade for Medicus Pharma.
When is the next analyst rating going to be posted or updated for Medicus Pharma (MDCX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Medicus Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Medicus Pharma was filed on June 23, 2025 so you should expect the next rating to be made available sometime around June 23, 2026.
Is the Analyst Rating Medicus Pharma (MDCX) correct?
While ratings are subjective and will change, the latest Medicus Pharma (MDCX) rating was a maintained with a price target of $27.00 to $27.00. The current price Medicus Pharma (MDCX) is trading at is $2.38, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
